253 related articles for article (PubMed ID: 8172849)
1. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution.
Brinton EA; Eisenberg S; Breslow JL
Arterioscler Thromb; 1994 May; 14(5):707-20. PubMed ID: 8172849
[TBL] [Abstract][Full Text] [Related]
2. Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia.
Brinton EA; Eisenberg S; Breslow JL
J Clin Invest; 1991 Feb; 87(2):536-44. PubMed ID: 1899429
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein A-I and A-II kinetic parameters as assessed by endogenous labeling with [(2)H(3)]leucine in middle-aged and elderly men and women.
Velez-Carrasco W; Lichtenstein AH; Li Z; Dolnikowski GG; Lamon-Fava S; Welty FK; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):801-6. PubMed ID: 10712406
[TBL] [Abstract][Full Text] [Related]
4. Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II.
De Oliveira E Silva ER; Foster D; McGee Harper M; Seidman CE; Smith JD; Breslow JL; Brinton EA
Circulation; 2000 Nov; 102(19):2347-52. PubMed ID: 11067787
[TBL] [Abstract][Full Text] [Related]
5. Metabolic and genetic determinants of HDL metabolism and hepatic lipase activity in normolipidemic females.
De Oliveira e Silva ER; Kong M; Han Z; Starr C; Kass EM; Juo SH; Foster D; Dansky HM; Merkel M; Cundey K; Brinton EA; Breslow JL; Smith JD
J Lipid Res; 1999 Jul; 40(7):1211-21. PubMed ID: 10393206
[TBL] [Abstract][Full Text] [Related]
6. Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women.
Brinton EA; Eisenberg S; Breslow JL
J Clin Invest; 1989 Jul; 84(1):262-9. PubMed ID: 2500457
[TBL] [Abstract][Full Text] [Related]
7. Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese men.
Ooi EM; Watts GF; Chan DC; Nielsen LB; Plomgaard P; Dahlbäck B; Barrett PH
Atherosclerosis; 2010 May; 210(1):326-30. PubMed ID: 20031132
[TBL] [Abstract][Full Text] [Related]
8. In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance.
Pietzsch J; Julius U; Nitzsche S; Hanefeld M
Diabetes; 1998 Dec; 47(12):1928-34. PubMed ID: 9836526
[TBL] [Abstract][Full Text] [Related]
9. A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates.
Brinton EA; Eisenberg S; Breslow JL
J Clin Invest; 1990 Jan; 85(1):144-51. PubMed ID: 2104877
[TBL] [Abstract][Full Text] [Related]
10. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
[TBL] [Abstract][Full Text] [Related]
11. Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia.
Kuusi T; Ehnholm C; Viikari J; Härkönen R; Vartiainen E; Puska P; Taskinen MR
J Lipid Res; 1989 Aug; 30(8):1117-26. PubMed ID: 2504859
[TBL] [Abstract][Full Text] [Related]
12. ApoA-II maintains HDL levels in part by inhibition of hepatic lipase. Studies In apoA-II and hepatic lipase double knockout mice.
Weng W; Brandenburg NA; Zhong S; Halkias J; Wu L; Jiang XC; Tall A; Breslow JL
J Lipid Res; 1999 Jun; 40(6):1064-70. PubMed ID: 10357838
[TBL] [Abstract][Full Text] [Related]
13. Dietary restriction of saturated fat and cholesterol decreases HDL ApoA-I secretion.
Vélez-Carrasco W; Lichtenstein AH; Welty FK; Li Z; Lamon-Fava S; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):918-24. PubMed ID: 10195918
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein metabolism in subjects with hepatic lipase deficiency.
Tilly-Kiesi M; Schaefer EJ; Knudsen P; Welty FK; Dolnikowski GG; Taskinen MR; Lichtenstein AH
Metabolism; 2004 Apr; 53(4):520-5. PubMed ID: 15045702
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein B-100 and apoA-II kinetics as determinants of cellular cholesterol efflux.
Chan DC; Hoang A; Barrett PH; Wong AT; Nestel PJ; Sviridov D; Watts GF
J Clin Endocrinol Metab; 2012 Sep; 97(9):E1658-66. PubMed ID: 22745238
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein AI and AII metabolism in patients with primary high-density lipoprotein deficiency associated with familial hypertriglyceridemia.
Saku K; Gartside PS; Hynd BA; Mendoza SG; Kashyap ML
Metabolism; 1985 Aug; 34(8):754-64. PubMed ID: 3927110
[TBL] [Abstract][Full Text] [Related]
17. High-density lipoprotein apolipoprotein A-I kinetics: comparison of radioactive and stable isotope studies.
Ooi EM; Watts GF; Farvid MS; Chan DC; Allen MC; Zilko SR; Barrett PH
Eur J Clin Invest; 2006 Sep; 36(9):626-32. PubMed ID: 16919045
[TBL] [Abstract][Full Text] [Related]
18. Independent regulation of plasma apolipoprotein C-II and C-III concentrations in very low density and high density lipoproteins: implications for the regulation of the catabolism of these lipoproteins.
Le NA; Gibson JC; Ginsberg HN
J Lipid Res; 1988 May; 29(5):669-77. PubMed ID: 3411241
[TBL] [Abstract][Full Text] [Related]
19. Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men.
Chan DC; Barrett PH; Ooi EM; Ji J; Chan DT; Watts GF
J Clin Endocrinol Metab; 2009 Mar; 94(3):989-97. PubMed ID: 19116237
[TBL] [Abstract][Full Text] [Related]
20. Roles of high apolipoprotein E blood levels and HDL in development of familial dysbetalipoproteinemia in ε2ε2 subjects.
Corsetti JP; Sparks CE; Bakker SJL; Gruppen EG; Dullaart RPF
Clin Biochem; 2018 Feb; 52():67-72. PubMed ID: 29157655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
